Microencapsulated pendimethalin comprising alkali or alkaline earth metal salt of organic acid
A microencapsulated formulation of pendimethalin comprising an alkali or an alkaline earth metal salt of an organic acid. Also described are processes for the preparation of the formulation and a method of controlling weeds at a location by using the described formulation.
1. A capsule suspension formulation of pendimethalin comprising microcapsules comprising pendimethalin encapsulated within a polymeric wall formed in-situ by an interfacial polymerization reaction occurring between an organic phase dispersed in an aqueous phase, said aqueous phase comprising at least one alkali or alkaline earth metal salt of an organic acid, wherein said organic acid is selected from the group consisting of acetic acid, propionic acid, citric acid, fumaric acid, tartaric acid, oxalic acid, succinic acid, valeric acid, malonic acid, glutaric acid, adipic acid and phthalic acid, with the proviso that the aqueous phase does not comprise an inorganic salt prior to formation of the polymeric wall, wherein the formulation comprises about 5% to about 60% pendimethalin by weight, about 1% to about 20% polymeric wall by weight, and about 2% to about 55% the at least one alkali or alkaline earth metal salt of an organic acid by weight.
2. The formulation as claimed in claim 1 , having a reduced staining property over an encapsulated pendimethalin formulation comprising an inorganic salt within the microcapsule.
3. The formulation as claimed in claim 1 , wherein said polymeric wall is selected the group consisting of polyurea, polyurethane, polyamide, polycarbonate, polysulfonamide and crosslinked or non-crosslinked combinations thereof.
4. The formulation as claimed in claim 3 , wherein the polymeric wall is a polyurea wall.
5. The formulation as claimed in claim 1 , wherein said polymeric wall is formed by an interfacial polymerization triggered by contacting a first wall forming component with a second wall forming component.
6. The formulation as claimed in claim 5 , wherein said first and second wall forming components, being same or different, are included within at least one of said organic and aqueous phases.
7. The formulation as claimed in claim 5 , wherein said first wall forming component is selected from the group consisting of polyisocyanate, polyacid chloride, polychloroformate and polysulfonyl chloride.
8. The formulation as claimed in claim 5 , wherein said second wall forming component is selected from the group consisting of polyamine and polyol.
9. The formulation as claimed in claim 7 , wherein said first wall forming component is selected from the group consisting of tetramethylene diisocyanate, pentamethylene diisocyanate, hexamethylene diisocyanate, toluene diisocyanate, diphenylmethene-4,4′-diisocyanate, polymethylene polyphenylene isocynate, 2,4,4′-diphenyl ether triisocyanate, 3,3′-dimethyl-4,4′-diphenyl diisocyanate, 3,3′-dimethoxy-4,4′-diphenyl diisocyanate, 1,5-naphthylene diisocyanate and 4,4′4″-triphenylmethane triisocyanate.
10. The formulation as claimed in claim 5 , wherein said first wall forming component is present in an amount of about 0.1% to about 20% by weight of the organic phase.
11. The formulation as claimed in claim 5 , wherein said second wall forming component is present in an amount of about 0.3% to 7.5% by weight relative to the total weight of the formulation.
12. The formulation as claimed in claim 4 , wherein said polyurea wall is formed by a self-condensation reaction of a polyisocyanate wall forming component.
13. The formulation as claimed in claim 1 , wherein said alkali or alkaline earth metal moiety of said alkali or alkaline earth metal salt of an organic acid is selected from the group consisting of sodium and potassium.
14. The formulation as claimed in claim 1 , wherein said alkali or alkaline earth metal salt of an organic acid is sodium acetate or disodium succinate.
15. The formulation as claimed in claim 1 , wherein said microcapsules have a particle size of about 2 micrometers to about 50 micrometers.
16. The formulation as claimed in claim 1 further comprising at least one excipient selected from the group consisting of an anti-foam in an amount of about 0.01% to about 5% by weight of the formulation, a rheology modifier in an amount of about 0.01% to about 3% by weight of the formulation, a mineral acid from about 0.1% to about 10% by weight of the formulation and a biocide in an amount of from about 0.01% to about 3% by weight of the formulation.
17. A capsule suspension formulation of pendimethalin comprising from about 5% to about 60% of pendimethalin active ingredient by weight, said pendimethalin being encapsulated within a microcapsule comprising a polyurea wall comprising from about 1% by weight to about 20% by weight of the formulation, said polyurea wall being in-situ formed by an interfacial polymerization reaction occurring between an organic phase dispersed in an aqueous phase, said organic phase comprising a polyisocyanate wall forming component and said aqueous phase being characterized in consisting essentially of a pre-defined amount of a salt selected from sodium acetate or disodium succinate, with the proviso that the aqueous phase does not comprise an inorganic salt prior to formation of the polyurea wall.
18. A method for controlling undesirable plant species at a locus, said method comprising applying to the desired locus a herbicidally effective amount of a formulation as claimed in claim 1 .